Trevor McGoldrick

Structural Variants at the <i>BRCA1/2</i> Loci are a Common Source of Homologous Repair Deficiency in High-grade Serous Ovarian Carcinoma

Ailith Ewing, Alison Meynert, Michael Churchman et al. · Clinical Cancer Research · 2021 · 43 citations · Full text

Life Sciences, Genetics, Oncology +17

Renal cysteine conjugate C-S lyase mediated toxicity of halogenated alkenes in primary cultures of human and rat proximal tubular cells

Trevor McGoldrick, Edward A. Lock, Vicente Rodilla et al. · Archives of Toxicology · 2003 · 42 citations

Medicine, Biochemistry, Toxicology +14

Routine germline <i><scp>BRCA</scp>1</i> and <i><scp>BRCA</scp>2</i> testing in patients with ovarian carcinoma: analysis of the Scottish real‐life experience

K. Rust, Pavlina Spiliopoulou, CY Tang et al. · BJOG An International Journal of Obstetrics & Gynaecology · 2018 · 31 citations · Full text

Medicine, Genetics, Oncology +17

Safety and efficacy results from two randomized expansions of a phase I study of a tablet formulation of the PARP inhibitor, olaparib, in ovarian and breast cancer patients with <i>BRCA</i>1/2 mutations.

L Rhoda Molife, Joaquı́n Mateo, Trevor McGoldrick et al. · Journal of Clinical Oncology · 2012 · 16 citations

Pharmacy, Oncology, Pharmacology +17

Divergent trajectories to structural diversity impact patient survival in high grade serous ovarian cancer

Ailith Ewing, Alison Meynert, Ryan Silk et al. · Nature Communications · 2025 · 10 citations · Full text

Life Sciences, Genetics, Oncology +17